Founder and CEO, Reflex Medical & Tulavi Therapeutics
Corinne Bright is the Founder and CEO of Reflex Medical, a start-up company developing minimally invasive neuromodulatory devices to treat large unmet clinical needs. Prior to that, she was a Principal at ONSET Ventures, focusing on medical device and HCIT investments. Previously, she was Vice President, Research and Development at Talima Therapeutics, a privately-held start-up company developing a drug-device combination product for the local treatment of onychomycosis. At Talima, she led the development of their product from bench through Phase II clinical trials. Corinne has also developed technologies for applications in orthopedics, ENT, neurosurgery and interventional cardiology. Prior to Talima, she was a Biodesign Innovation Fellow at Stanford University. Corinne holds a B.S. in Engineering from Swarthmore College and a Ph.D. in Biomedical Engineering from Johns Hopkins School of Medicine where she focused on the development of novel therapies for treating spinal cord injury.